Trial Status Completed

Clinical Trials - Completed

The clinical trials listed in this section have ended and are no longer treating patients - all recruitment and follow-up has completed. Often the results will affect clinical practice, future treatment of patients and may lead to new clinical trials or further research. Members can review the Trial Report in the Members Area.

Filter AGITG trials by

Sorry

There are no trials at this stage of development for the chosen filters

Biliary tract cancers are uncommon; as a result it is not a well-studied disease and treatment options for this condition are limited. This study will assess the impact of a new combination of chemotherapy drugs on the growth of the cancer and the undesirable side-effects of treatment. Read More

This study will help to decide which treatments are most promising and should be compared with current treatments in the future in an effort to improve the time people live after a diagnosis of oesophageal or gastric cancer. Read More

PETACC-6 aims to investigate if using a combination of capecitabine with oxaliplatin as chemotherapy in the pre- and post-operative treatment setting reduces the risk of recurrence or death in patients with locally advanced rectal cancer. Read More

The ICECREAM study aims to provide important data on the optimal use of currently available therapeutics in patients with metastatic colorectal cancer who have progressed on standard chemotherapy options. The trial is designed to answer two questions in parallel. Read More

The DOCTOR study aims to compare the effectiveness of pre-operative treatment with cisplatin, 5 fluorouracil and docetaxel, with or without radiotherapy, in treating people who have shown a poor early response to standard chemotherapy for adenocarcinoma of the oesophagus and/or gastroesophageal junction. Read More